HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Over 15 years' experience in both finance and healthcare, covering clinic operations, investment and equity research in both China and overseas.

LinkDoc Technology (LDOC.US) - Here Are the Concerns

LinkDoc (零氪科技) Pre-IPO - Peer Comparison - A Niche that Doesn’t Give a Clear Advantage

LinkDoc (零氪科技) Pre-IPO - Thoughts on Valuation

JD Health (6618.HK) - Opportunities Coexist with Challenges

Industry Report - Insights on China Digital Healthcare Industry

Ping An Good Doctor (1833.HK) - It Is the Time to Look at Some Concerns

Battle Lines Drawn As BABA Builds Out First/Last-Mile Capacity; But Who Will Fund 75+ Bn CNY CapEx?

Equity Bottom-Up

<p>On January 15, 2021, the leading healthcare big data solution provider <a href="https://www.smartkarma.com/entities/yidu-tech-inc" target="_blank" data-smartkarma-citation="entities:29245:1" rel="noopener">Yidu Tech Inc (2158 HK) </a>was officially listed on the main board of Hong Kong Stock Exchange. The first-day trading of Yidu closed at HK$65.20/share, up 147.91% from the issue price of HK$26.30, with a market value of about HK$58 billion. As of March 23, 2021, Yidu had a market value of about HK$37 billion, down nearly 36% from its market value at the high point when it went public. So are there any concerns for the Company and how are the prospects for different business segments? </p>

On January 15, 2021, the leading healthcare big data solution provider Yidu Tech Inc (2158 HK) was officially listed on the main board of Hong Kong Stock Exchange. The first-day trading of Yidu closed at HK$65.20/share, up 147.91% from the issue price of HK$26.30, with a market value of about HK$58 billion. As of March 23, 2021, Yidu had a market value of about HK$37 billion, down nearly 36% from its market value at the high point when it went public. So are there any concerns for the Company and how are the prospects for different business segments? 

Ping An Healthcare and Technology (1833 HK)

Yidu Tech Inc (2158.HK) - Here Are the Business Prospects and Challenges